Q4 2024 · 13F-HR/A
Rosalind Advisors, Inc.holdings as filed
Filed 2025-02-14 · accession 0001622627-25-000016
$195.6M
Reported value
40
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 24661P807 | DCTH | DELCATH SYS INC | $31.9M | 16.3% | 2,650,389 | Common | SOLE |
| 62857J201 | MYO | MYOMO INC | $19.3M | 9.88% | 2,998,945 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $11.2M | 5.72% | 628,050 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $10.6M | 5.43% | 3,050,000 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $10.5M | 5.38% | 3,104,995 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $10.1M | 5.14% | 1,805,390 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $9.6M | 4.93% | 1,128,700 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $9.3M | 4.74% | 870,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $8.2M | 4.17% | 2,654,944 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $8.0M | 4.07% | 1,259,876 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $7.2M | 3.66% | 810,918 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $7.0M | 3.56% | 150,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $6.6M | 3.36% | 2,495,783 | Common | SOLE |
| 68404V209 | OPTNUSD | OPTINOSE INC | $5.9M | 3.00% | 876,996 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MED CORP | $5.2M | 2.66% | 692,185 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $4.7M | 2.38% | 900,000 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $4.4M | 2.24% | 1,062,500 | Common | SOLE |
| 14817C957 | — | CASSAVA SCIENCES INC | $3.7M | 1.87% | 417,400 | PUT | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $3.1M | 1.61% | 260,000 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $3.1M | 1.58% | 1,018,021 | Common | SOLE |
| 09077A956 | — | BIOMEA FUSION INC | $2.8M | 1.41% | 910,700 | PUT | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $2.7M | 1.37% | 707,625 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $2.6M | 1.32% | 303,864 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $1.5M | 0.76% | 252,753 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $985,064 | 0.50% | 417,400 | Common | SOLE |
| 21900C908 | — | CORMEDIX INC | $919,500 | 0.47% | 183,900 | CALL | SOLE |
| 09077D209 | BFRI | BIOFRONTERA INC | $884,991 | 0.45% | 811,918 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $826,832 | 0.42% | 250,555 | Common | SOLE |
| 28036F955 | — | EDGEWISE THERAPEUTICS INC | $807,500 | 0.41% | 237,500 | PUT | SOLE |
| 464287955 | — | ISHARES TR | $404,000 | 0.21% | 200,000 | PUT | SOLE |
| 46090E953 | — | INVESCO QQQ TR | $356,000 | 0.18% | 100,000 | PUT | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $321,765 | 0.16% | 613,939 | Common | SOLE |
| 78464A950 | — | SPDR SER TR | $311,000 | 0.16% | 800,000 | PUT | SOLE |
| 640979950 | — | NEUMORA THERAPEUTICS INC. | $300,240 | 0.15% | 136,600 | PUT | SOLE |
| 528872902 | — | LEXICON PHARMACEUTICALS INC | $281,835 | 0.14% | 1,278,900 | CALL | SOLE |
| 69120X206 | OWLT | OWLET INC | $220,012 | 0.11% | 49,441 | Common | SOLE |
| 75955J952 | — | RELMADA THERAPEUTICS INC | $95,000 | 0.05% | 100,000 | PUT | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $52,000 | 0.03% | 100,000 | Common | SOLE |
| 78464A900 | — | SPDR SER TR | $22,000 | 0.01% | 1,400,000 | CALL | SOLE |
| 137404959 | — | CANDEL THERAPEUTICS INC | $480 | 0.00% | 262,500 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.